Parte Receptora definition

Parte Receptora es la parte que recibe Información Confidencial en virtud de este Contrato.
Sample 1Sample 2
Parte Receptora é a parte que receber as Informações Confidenciais relativas à outra parte.
Sample 1
Parte Receptora possui o significado atribuído na cláusula 34.1;
Sample 1

Examples of Parte Receptora in a sentence

  • La Parte Receptora protegerá y preservará la Información Confidencial como confidencial, con al menos el mismo cuidado con el que protege y preserva su propia información confidencial y de su titularidad (pero en ningún caso con un nivel de diligencia que sea menor a un grado razonable de cuidado) y no usará la Información Confidencial para propósito alguno excepto cuando sea necesario para llevar a cabo sus obligaciones bajo este Contrato.

  • Durante el Período, cualquiera de las Partes puede recibir (la "Parte Receptora") cierta información y materiales relacionados con los negocios, tecnología, clientes y productos de la otra Parte que xxxx confidenciales y de valor sustancial para la otra Parte (la "Parte Divulgadora").

  • La Parte Receptora no estará impedida de cumplir con la revelación ordenada por xx xxx aplicable si, donde fuera razonablemente viable y sin que implique el incumplimiento de cualquier requerimiento legal o regulatorio, diera previo aviso por escrito a la Parte Revelante del requerimiento de revelación.

  • Si la Parte Receptora viniera obligada por ley o por cualquier normativa o resolución administrativa o judicial a revelar dicha Información Confidencial, la Parte Receptora únicamente revelará aquella parte de dicha Información Confidencial que la Parte Receptora, en opinión de su asesor jurídico, viniera legalmente obligada a facilitar, y realizará esfuerzos razonables a efectos de mantener la confidencialidad del resto de la Información Confidencial de la Parte Reveladora.

  • La Parte Receptora podrá revelar la Información Confidencial, si así le fuera exigido por la legislación aplicable o por cualquier resolución judicial o normativa administrativa, o por cualquier autoridad administrativa u otra autoridad reguladora.

  • La Parte Receptora no podrá, en ningún momento y bajo ninguna circunstancia, reclamar o cuestionar la titularidad, propiedad, o cualesquiera derechos relativos a la Información Confidencial y no permitirá a ninguna tercera parte actuar de ese modo, directa o indirectamente.

  • La "Información Confidencial" consiste en (a) cualquier información técnica o planes relativos a los Servicios, la Plataforma o cualquier software u otra tecnología de Taboola o de las Propiedades; (b) cualquier información financiera del Editor; (c) otra información revelada por la Parte Divulgadora a la Parte Receptora que se marque como confidencial o se debería asumir razonablemente que es confidencial en atención a las circunstancias; y (d) el contenido de este Contrato.

  • Si una Parte está obligada a retener o deducir Impuestos de un pago que deba efectuar, entonces esa Parte ("Parte Pagadora") notificará inmediatamente a la otra Parte ("Parte Receptora") dicha obligación y pagará a las autoridades competentes todas las cantidades a retener o deducir por ella.

  • Si puede expedirse un recibo u otra prueba que acredite el pago a las autoridades, la Parte Pagadora entregará dicha prueba (o una copia certificada de la misma) a la Parte Receptora.

  • La Parte Receptora podrá revelar Información Confidencial si se lo exige xx xxx, la reglamentación u orden judicial aplicable, pero cuando esté legalmente permitido y sea viable, enviará notificación previa a la Parte Reveladora para permitirle solicitar una orden de protección u otra protección similar.


More Definitions of Parte Receptora

Parte Receptora es la parte que recibe Información Confidencial conforme a este Contrato. “Parte Reveladora” es la parte que revela Información Confidencial conforme a
Sample 1

Related to Parte Receptora

  • Receptor means enclosed spaces, conduits, protected groundwater sources, drinking and non-drinking water wells, surface water bodies, and public water systems which when impacted by chemicals of concern may result in exposure to humans and aquatic life, explosive conditions or other adverse effects on health, safety and the environment as specified in these rules.

  • Image receptor means any device, such as a fluorescent screen or radiographic film, which transforms incident X-ray photons either into a visible image or into another form which can be made into a visible image by further transformations.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Preceptor means an individual who provides, directs, or verifies training and experience required for an individual to become an authorized user, an authorized medical physicist, an authorized nuclear pharmacist, or a radiation safety officer.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • DNA profile means a letter or number code which represents a set of identification characteristics of the non-coding part of an analysed human DNA sample, i.e. the particular molecular structure at the various DNA locations (loci);

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Diagnostic mammography means a method of screening that

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Librarian means an educator who provides full-time library ser- vices and holds the relevant certificate from SBEC.

  • HEPA filter means high-efficiency particulate air filters that are rated to achieve a minimum initial particle-removal efficiency of 99.97 per cent using ASTM F 1471– 93 or equivalent standard;

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Attack directed against any civilian population means a course of conduct involving the multiple commission of acts referred to in paragraph 1 against any civilian population, pursuant to or in furtherance of a State or organizational policy to commit such attack;

  • Pharmacist preceptor or “preceptor” means a pharmacist licensed to practice pharmacy whose license is current and in good standing. Preceptors shall meet the conditions and requirements of rule 657—4.9(155A). No pharmacist shall serve as a preceptor while the pharmacist’s license to practice pharmacy is the subject of disciplinary sanction by a pharmacist licensing authority.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • obsrvd_agnt_cd ;"count erparty_identifier";"entty_rl";"cntrct_id";"instrmnt_id";" reporting_reference_date" Alpha-numeric Semicolon-separated string of all column names. Field names are put in double quotation marks. 1 reporting_agent_identifier Variable characters (60) 60 identifier domain 2 obsrvd_agnt_cd Variable characters (60) 60 identifier domain 3 counterparty_identifier Variable characters (60) 60 identifier domain 4 entty_rl Variable characters (25) 25 counterparty-instrument role type 5 cntrct_id Variable characters (60) 60 identifier domain 6 instrmnt_id Variable characters (60) 60 identifier domain 7 reporting_reference_date Date reporting reference date

  • Clinical Trial means any human clinical trial of a Product.

  • Opioid antagonist means a drug that binds to opioid

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Program Patents has the meaning set forth in Section 7.1.2.

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.